Alice Park
Showing 1–3 of 3 transcripts.
- Milken Institute1h 4m
Innovation Beyond Borders: New Approaches Transforming Health | Global Conference 2025
Alice Park, Mansoor Ibrahim Al Mansoori, Olivier Bogillot, Geetha Tharmaratnam, Prashant Warier
Global health leaders are driving a paradigm shift from reactive disease management to proactive prevention by integrating genomic data, AI-driven diagnostics, and social determinants into unified population intelligence platforms. Pioneering initiatives in Abu Dhabi demonstrate how merging clinical records with lifestyle metrics and enforcing strict data sovereignty can accelerate the regulatory approval of preventive therapies and reduce hospitalization rates. This systemic transformation aims to treat longevity as a universal birthright, requiring coordinated policy, catalytic capital, and AI augmentation to rebuild healthcare infrastructure around sustainable health outcomes.
- Milken Institute1h 1m
Where Is the Next Cure? | Global Conference 2024
Alice Park, Noubar Afeyan, Aloe Blacc, Daphne Koller, Samarth Kulkarni, Pablo Legorreta
Leading biotech executives and researchers are redefining the industry by shifting from chronic small-molecule management to precise, curative systems-based therapies like CRISPR and mRNA platforms. This transition, fueled by artificial intelligence and a "reverse translation" innovation model, has accelerated clinical timelines while projecting a $100 billion market for GLP-1 drugs and new organ-editing solutions. Despite regulatory hurdles and high initial costs for treatments like sickle cell gene editing, stakeholders anticipate that maturing technologies and scalable manufacturing will eventually democratize access to these transformative medical breakthroughs.
- Milken Institute1h 11m
Global Collaboration to Eradicate Women’s Cancers | Future of Health Summit 2024
Alice Park, Usman Malami Aliyu, Danielle Carnival, Dave Fredrickson, Roberta Lipson, Gemma Peters
Global cancer leaders convened to address the projected doubling of incidence in low- and middle-income countries by implementing diverse strategies ranging from Nigeria's mobile screening vans and mobile PCR labs in China to the UK's data-driven risk assessment partnerships. These initiatives prioritize overcoming structural inequities in treatment access, financial barriers, and clinical trial participation through innovations like AI-driven imaging, drug repurposing, and targeted care navigation programs. Ultimately, the consensus emphasizes that sustainable national cancer control plans must integrate geopolitical cooperation and equity-first designs to prevent the fragmentation of global research and ensure effective prevention for the most vulnerable populations.